QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR
Overall QIA gets a fundamental rating of 6 out of 10. We evaluated QIA against 18 industry peers in the Life Sciences Tools & Services industry. QIA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. QIA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIA was profitable.
QIA had a positive operating cash flow in the past year.
QIA had positive earnings in each of the past 5 years.
QIA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QIA has a Return On Assets of 1.47%. This is in the lower half of the industry: QIA underperforms 66.67% of its industry peers.
With a Return On Equity value of 2.34%, QIA is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
QIA has a better Return On Invested Capital (7.14%) than 72.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QIA is in line with the industry average of 6.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
With a Profit Margin value of 4.23%, QIA perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
In the last couple of years the Profit Margin of QIA has declined.
Looking at the Operating Margin, with a value of 25.02%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of QIA has grown nicely.
Looking at the Gross Margin, with a value of 63.82%, QIA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
QIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
QIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
The debt/assets ratio for QIA has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.29 indicates that QIA is not in any danger for bankruptcy at the moment.
QIA has a Altman-Z score of 4.29. This is amongst the best in the industry. QIA outperforms 94.44% of its industry peers.
The Debt to FCF ratio of QIA is 2.77, which is a good value as it means it would take QIA, 2.77 years of fcf income to pay off all of its debts.
QIA has a Debt to FCF ratio of 2.77. This is amongst the best in the industry. QIA outperforms 83.33% of its industry peers.
QIA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
QIA has a Debt to Equity ratio of 0.38. This is in the better half of the industry: QIA outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.29 |
ROIC/WACC0.93
WACC7.68%
2.3 Liquidity
A Current Ratio of 3.61 indicates that QIA has no problem at all paying its short term obligations.
The Current ratio of QIA (3.61) is better than 100.00% of its industry peers.
QIA has a Quick Ratio of 3.09. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a better Quick ratio (3.09) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.95%, which is quite good.
Measured over the past years, QIA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.25% on average per year.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.66%.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
QIA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.51% yearly.
QIA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y7.51%
Revenue Next Year4.01%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y8.27%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.80, the valuation of QIA can be described as rather expensive.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of QIA to the average of the S&P500 Index (26.29), we can say QIA is valued slightly cheaper.
The Price/Forward Earnings ratio is 17.57, which indicates a rather expensive current valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of QIA to the average of the S&P500 Index (22.17), we can say QIA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.8 | ||
| Fwd PE | 17.57 |
4.2 Price Multiples
QIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QIA is cheaper than 66.67% of the companies in the same industry.
QIA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. QIA is cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.6 | ||
| EV/EBITDA | 13.61 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.45
PEG (5Y)2.4
EPS Next 2Y8.28%
EPS Next 3Y9%
5. Dividend
5.1 Amount
No dividends for QIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QIA (6/3/2025, 4:58:09 PM)
39.805
+0.35 (+0.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap8.62B
Analysts76
Price Target44.8 (12.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)1.97%
PT rev (3m)-10.18%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)2.06%
EPS NY rev (3m)1.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)1.16%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.8 | ||
| Fwd PE | 17.57 | ||
| P/S | 4.98 | ||
| P/FCF | 19.6 | ||
| P/OCF | 14.61 | ||
| P/B | 2.76 | ||
| P/tB | 11.74 | ||
| EV/EBITDA | 13.61 |
EPS(TTM)2.01
EY5.05%
EPS(NY)2.27
Fwd EY5.69%
FCF(TTM)2.03
FCFY5.1%
OCF(TTM)2.72
OCFY6.84%
SpS8
BVpS14.43
TBVpS3.39
PEG (NY)2.45
PEG (5Y)2.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.29 |
F-Score7
WACC7.68%
ROIC/WACC0.93
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y7.51%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.01%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y8.27%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.09%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%